CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated other comprehensive income (loss)	Non-Controlling Interest	Total
Balance at beginning of year at Dec. 31, 2021	$ 345	$ 60,628	$ (251,725)	$ 12,018	$ 2,736	$ (175,998)
Balance at beginning of year (in shares) at Dec. 31, 2021	34,523,000
Net income (loss)			(55,185)		(276)	(55,461)
Issuance of common shares upon closing of de-SPAC merger transaction, net of issuance costs, net of $3,178 of taxes	$ 129	1,738				1,867
Issuance of common shares upon closing of de-SPAC merger transaction, net of issuance costs, net of $3,178 of taxes (in shares)	12,868,000
Issuance of common shares related to PIPE financing	$ 206	205,694				205,900
Issuance of common shares related to PIPE financing (in shares)	20,590,000
Issuance of common shares related to conversion of debt to equity	$ 25	24,975				25,000
Issuance of common shares related to conversion of debt to equity (in shares)	2,500,000
Issuance of common shares, net of issuance costs	$ 22	23,731				23,753
Issuance of common shares, net of issuance costs (in shares)	2,220,000
Issuance of common shares related to Public Warrant exercise	$ 1	1,272				1,273
Issuance of common shares related to Public Warrant exercise (in shares)	94,000
Issuance of common shares related to stock options exercised		375				375
Issuance of common shares related to stock options exercised (in shares)	39,000
Issuance of common shares related to acquisition	$ 19	23,416				23,435
Issuance of common shares related to acquisition (in shares)	1,853,000
Common Equivalent Preferred Unit dividends ($0.02 per unit)			(4,380)			(4,380)
Loss on extinguishment of Common Equivalent Preferred units			(2,870)			(2,870)
Accretion of Series A Convertible Preferred Shares		(1,316)				(1,316)
Other comprehensive income (loss)				(18,121)		(18,121)
Equity-based compensation	$ 3	2,628				2,631
Equity-based compensation (in shares)	333,000
Net share settlement of equity awards		(477)				(477)
Accumulating preferred dividends			(13,882)			(13,882)
Balance at end of year at Dec. 31, 2022	$ 750	342,664	(328,042)	(6,103)	2,460	11,729
Balance at end of year (in shares) at Dec. 31, 2022	75,020,000
Net income (loss)			(34,582)		15	(34,567)
Issuance of common shares, net of issuance costs	$ 119	117,648				117,767
Issuance of common shares, net of issuance costs (in shares)	11,877,000
Issuance of common shares related to acquisitions		446				446
Issuance of common shares related to acquisitions (in shares)	40,000
Issuance of common shares related to Public Warrant exercise	$ 2	3,142				3,144
Issuance of common shares related to Public Warrant exercise (in shares)	229,000
Issuance of common shares related to stock options exercised	$ 1	847				848
Issuance of common shares related to stock options exercised (in shares)	88,000
Issuance of common shares related to conversion of Series A Convertible Preferred Shares	$ 1	881				882
Issuance of common shares related to conversion of Series A Convertible Preferred Shares (in shares)	76,000
Issuance of common shares related to purchase of non-controlling interest	$ 1	474			$ (2,475)	(2,000)
Issuance of common shares related to purchase of non-controlling interest (in shares)	100,000
Accretion of Series A Convertible Preferred Shares		(161)				(161)
Other comprehensive income (loss)				9,921		9,921
Equity-based compensation	$ 6	8,702				8,708
Equity-based compensation (in shares)	621,000
Net share settlement of equity awards		(2,977)				(2,977)
Balance at end of year at Dec. 31, 2023	$ 880	471,666	(362,624)	3,818		113,740
Balance at end of year (in shares) at Dec. 31, 2023	88,051,000
Net income (loss)			(80,298)			(80,298)
Issuance of common shares related to "at-the-market" offering program, net of issuance costs	$ 1	624				625
Issuance of common shares related to "at-the-market" offering program, net of issuance costs (in shares)	60,000
Issuance of common shares related to stock options exercised		12				12
Issuance of common shares related to stock options exercised (in shares)	1,000
Issuance of common shares related to warrant exchange	$ 54	37,732				37,786
Issuance of common shares related to warrant exchange (in shares)	5,539,000
Issuance of common shares related to conversion of Series A Convertible Preferred Shares		16				$ 16
Issuance of common shares related to conversion of Series A Convertible Preferred Shares (in shares)	1,000
Issuance of common shares related to stock options exercised (in shares)						1,311
Accretion of Series A Convertible Preferred Shares		349				$ 349
Other comprehensive income (loss)				15,766		15,766
Equity-based compensation	$ 7	11,601				11,608
Equity-based compensation (in shares)	569,000
Net share settlement of equity awards		(2,122)				(2,122)
Balance at end of year at Dec. 31, 2024	$ 942	$ 519,878	$ (442,922)	$ 19,584		$ 97,482
Balance at end of year (in shares) at Dec. 31, 2024	94,221,000